IsoPlexis Corp

IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Argo Group International Holdings Ltd

Duck Creek Technologies

Oak Street Health

NEW YORK , Feb. 24, 2023 /PRNewswire/ --  If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law305 Broadway, 7th Floor New York, NY 10007 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com IsoPlexis Corporation (NASDAQ: ISO) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation (NASDAQ: ISO) in connection with its proposed acquisition by Berkeley Lights, Inc. ("Berkeley Lights").

SHAREHOLDER ALERT: Weiss Law Reminds ISO, ARGO, OSH, and DCT Shareholders About Its Ongoing Investigations

Berkeley Lights, Inc.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IsoPlexis Corporation (NasdaqGS: ISO) to Berkeley Lights, Inc. (NasdaqGS: BLI). Under the terms of the proposed transaction, shareholders of IsoPlexis will receive 0.612 shares of Berkeley Lights for each share of IsoPlexis that they own.

ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO

NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation ("IsoPlexis" or the "Company") (NASDAQ: ISO) in connection with its proposed acquisition by Berkeley Lights, Inc. ("Berkeley Lights") (NASDAQ: BLI). Under the merger agreement, the Company's shareholders will receive 0.612 shares of Berkeley Lights common stock for each IsoPlexis share, representing implied per-share consideration of $1.44 based upon Berkeley Lights' February 2, 2023 closing price of $2.36.

SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation

IEC Electronics Corp.

PORTLAND, Ore.--( BUSINESS WIRE )--SheerID, the global leader in identity marketing, today announced it has received ISO/IEC 27001:2013 certification status from the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC).

SheerID Achieves Updated Information Security-Based ISO/IEC Certification Status

BOSTON--( BUSINESS WIRE )--TSG Global announced it has completed the requirements to achieve ISO 27001 certification. The ISO 27001:2013 certification demonstrates TSG Global's commitment to offering the highest level of compliancy, privacy, information security and identity management for its customers.

TSG Global Receives ISO 27001 Certification for Security Management

TORONTO--( BUSINESS WIRE )--TechBlocks, a global I.T. consulting & software engineering firm has received ISO 27001 certification. ISO 27001 is an international standard to manage information security. The standard details requirements for establishing, implementing, maintaining and continually improving information security management systems (ISMS).

TechBlocks Receives ISO 27001 Certification

BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended December 31, 2022. Total revenue for the full year ended December 31, 2022 is expected to be in the range of $16.6 to $16.8 million, representing a decrease of approximately 3% to 4% compared to $17.3 million for the full year ended December 31, 2021.

IsoPlexis Reports Preliminary Full Year 2022 Revenue

New York, New York--(Newsfile Corp. - December 27, 2022) - Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating IsoPlexis Corp. (NASDAQ: ISO), relating to its proposed sale to Berkeley Lights, Inc.

EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of IsoPlexis Corp. - ISO

Wilmington, Delaware--(Newsfile Corp. - December 23, 2022) - Rigrodsky Law, P.A. is investigating IsoPlexis Corporation ("IsoPlexis") (NASDAQ: ISO) regarding possible breaches of fiduciary duties and other violations of law related to IsoPlexis' agreement to be acquired by Berkeley Lights, Inc. ("Berkeley"). Under the terms of the agreement, IsoPlexis' shareholders will receive 0.612 shares of Berkeley per share.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-isoplexis-corporation.To contact Seth D.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IsoPlexis Corporation Buyout

IsoPlexis (NASDAQ: ISO ) stock is jumping more than 80% today on news that the company will join forces with Berkeley Lights (NASDAQ: BLI ). The two names will combine into a new company called PhenomeX.

Why Is IsoPlexis (ISO) Stock Up 80% Today?

MILWAUKEE , Dec. 21, 2022 /PRNewswire/ -- Ademi LLP is investigating IsoPlexis (Nasdaq: ISO) for possible breaches of fiduciary duty and other violations of law in its transaction with Berkeley Lights.  Click here to learn how to join the action https://www.ademilaw.com/case/isoplexis-corporation or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether IsoPlexis Corporation has obtained a Fair Price in its transaction with Berkeley Lights

NEW YORK--( BUSINESS WIRE )--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of IsoPlexis Corporation (NASDAQ: ISO) to Berkeley Lights, Inc. for 0.612 shares of Berkeley stock for each IsoPlexis share is fair to IsoPlexis shareholders. Following the close of the transaction, IsoPlexis shareholders will own approximately 24.8% of the combined company.

ISO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of IsoPlexis Corporation Is Fair to Shareholders

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

IsoPlexis Corporation (NASDAQ:ISO ) Q3 2022 Earnings Conference Call November 10, 2022 5:30 PM ET Company Participants Carrie Mendivil - IR Sean Mackay - CEO John Strahley - CFO Conference Call Participants Jordan Adler - Evercore ISI Joe Giordano - Cowen Michael Jones - SVB Securities Edmund Tu - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the IsoPlexis Third Quarter 2022 Earnings Conference Call.

IsoPlexis Corporation (ISO) Q3 2022 Earnings Call Transcript

BRANFORD, Conn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today reported financial results for the quarter ended September 30, 2022.

IsoPlexis Reports Third Quarter 2022 Financial Results

BRANFORD, Conn., Nov. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the following investor conferences.

IsoPlexis to Participate in Upcoming Investor Conferences

BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will report financial results for the third quarter 2022 before market open on Thursday, November 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

BRANFORD, Conn., Sept. 13, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the publication of initial data off its CodePlex platform in the journal Scientific Reports carried out by researchers at the Shanghai Institute of Hematology.

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

Large multi-site COVID-19 study to use IsoPlexis Single Cell Functional Proteomics to survey immunity. Large multi-site COVID-19 study to use IsoPlexis Single Cell Functional Proteomics to survey immunity.

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

BRANFORD, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

BRANFORD, Conn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director.

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

IsoPlexis Corporation (NASDAQ:ISO ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Carrie Mendivil - IR Sean Mackay - CEO John Strahley - CFO Conference Call Participants Vijay Kumar - Evercore Max Masucci - Cowen Puneet Souda - SVB Leerink Tejas Savant - Morgan Stanley Operator Good morning ladies and gentlemen, thank you for standing by. And welcome to IsoPlexis' Second Quarter 2022 Earnings Conference Call.

IsoPlexis Corporation (ISO) CEO Sean Mackay on Q2 2022 Results Earnings Call Transcript

BRANFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today reported financial results for the quarter ended June 30, 2022.

IsoPlexis Reports Second Quarter 2022 Financial Results

BRANFORD, Conn., July 21, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the second quarter 2022 before market open on Wednesday, August 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022

First quarter 2022 revenue increased 52% over prior year period First quarter 2022 revenue increased 52% over prior year period

News for IsoPlexis Corp Stock (ISO)